Emodin Bidirectionally Modulates Macrophage Polarization and Epigenetically Regulates Macrophage Memory*

Macrophages are pleiotropic cells capable of performing a broad spectrum of functions. Macrophage phenotypes are classified along a continuum between the extremes of proinflammatory M1 macrophages and anti-inflammatory M2 macrophages. The seemingly opposing functions of M1 and M2 macrophages must be tightly regulated for an effective and proper response to foreign molecules or damaged tissue. Excessive activation of either M1 or M2 macrophages contributes to the pathology of many diseases. Emodin is a Chinese herb-derived compound and has shown potential to inhibit inflammation in various settings. In this study, we tested the ability of emodin to modulate the macrophage response to both M1 and M2 stimuli. Primary mouse macrophages were stimulated with LPS/IFNγ or IL4 with or without emodin, and the effects of emodin on gene transcription, cell signaling pathways, and histone modifications were examined by a variety of approaches, including microarray, quantitative real-time PCR, Western blotting, chromatin immunoprecipitation, and functional assays. We found that emodin bidirectionally tunes the induction of LPS/IFNγ- and IL4-responsive genes through inhibiting NFκB/IRF5/STAT1 signaling and IRF4/STAT6 signaling, respectively. Thereby, emodin modulates macrophage phagocytosis, migration, and NO production. Furthermore, emodin inhibited the removal of H3K27 trimethylation (H3K27m3) marks and the addition of H3K27 acetylation (H3K27ac) marks on genes required for M1 or M2 polarization of macrophages. In conclusion, our data suggest that emodin is uniquely able to suppress the excessive response of macrophages to both M1 and M2 stimuli and therefore has the potential to restore macrophage homeostasis in various pathologies.

[1]  M. B. Gillespie,et al.  Human papillomavirus status and gene expression profiles of oropharyngeal and oral cancers from European American and African American patients , 2016, Head & neck.

[2]  Yu-Shan Gao,et al.  Protective effect of emodin against airway inflammation in the ovalbumin-induced mouse model , 2015, Chinese Journal of Integrative Medicine.

[3]  Zhaoyang Sun,et al.  Development of phenylboronic acid-functionalized nanoparticles for emodin delivery. , 2015, Journal of materials chemistry. B.

[4]  Hong Liu,et al.  Attenuation of Inflammation by Emodin in Lipopolysaccharide-induced Acute Kidney Injury via Inhibition of Toll-like Receptor 2 Signal Pathway. , 2015, Iranian journal of kidney diseases.

[5]  A. Chawla,et al.  Alternatively activated macrophages promote pancreatic fibrosis in chronic pancreatitis , 2015, Nature Communications.

[6]  Yanning Liu,et al.  Emodin Protects Against Concanavalin A-Induced Hepatitis in Mice Through Inhibiting Activation of the p38 MAPK-NF-κB Signaling Pathway , 2015, Cellular Physiology and Biochemistry.

[7]  Wei Zhang,et al.  Emodin Ameliorates LPS-Induced Acute Lung Injury, Involving the Inactivation of NF-κB in Mice , 2014, International journal of molecular sciences.

[8]  Jun Hu,et al.  Emodin suppresses pulmonary metastasis of breast cancer accompanied with decreased macrophage recruitment and M2 polarization in the lungs , 2014, Breast Cancer Research and Treatment.

[9]  G. Bergström,et al.  Macrophage CD14 expression in human carotid plaques is associated with complicated lesions, correlates with thrombosis, and is reduced by angiotensin receptor blocker treatment. , 2014, International immunopharmacology.

[10]  B. Aggarwal,et al.  Downregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenols. , 2014, Archives of biochemistry and biophysics.

[11]  R. Xavier,et al.  Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity , 2014, Science.

[12]  Luosha Zhao,et al.  Emodin enhances cholesterol efflux by activating peroxisome proliferator‐activated receptor‐γ in oxidized low density lipoprotein‐loaded THP1 macrophages , 2014, Clinical and experimental pharmacology & physiology.

[13]  Xi-chen Zhang,et al.  Emodin inhibits LPS-induced inflammatory response by activating PPAR-γ in mouse mammary epithelial cells. , 2014, International immunopharmacology.

[14]  K. Wicks,et al.  Myeloid cell dysfunction and the pathogenesis of the diabetic chronic wound. , 2014, Seminars in immunology.

[15]  J. Olefsky,et al.  Macrophages, immunity, and metabolic disease. , 2014, Immunity.

[16]  S. Goerdt,et al.  Macrophage activation and polarization: nomenclature and experimental guidelines. , 2014, Immunity.

[17]  Jun Hu,et al.  Emodin attenuates systemic and liver inflammation in hyperlipidemic mice administrated with lipopolysaccharides , 2014, Experimental biology and medicine.

[18]  Trees Jansen,et al.  Trained Immunity or Tolerance: Opposing Functional Programs Induced in Human Monocytes after Engagement of Various Pattern Recognition Receptors , 2014, Clinical and Vaccine Immunology.

[19]  Jun Li,et al.  Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways. , 2014, Cellular signalling.

[20]  G. Sethi,et al.  Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer. , 2013, Cancer letters.

[21]  M. Takeya,et al.  Clinical significance of macrophage heterogeneity in human malignant tumors , 2013, Cancer science.

[22]  Eugenia G. Giannopoulou,et al.  Synergistic activation of inflammatory cytokine genes by interferon-γ-induced chromatin remodeling and toll-like receptor signaling. , 2013, Immunity.

[23]  M. Nahrendorf,et al.  Monocyte and Macrophage Heterogeneity in the Heart , 2013, Circulation research.

[24]  L. Ivashkiv.  Epigenetic regulation of macrophage polarization and function. , 2013, Trends in immunology.

[25]  J. Pollard,et al.  Macrophage biology in development, homeostasis and disease , 2013, Nature.

[26]  C. Glass,et al.  Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities , 2013, Science.

[27]  M. Schwartz,et al.  Harnessing monocyte‐derived macrophages to control central nervous system pathologies: no longer ‘if’ but ‘how’ , 2013, The Journal of pathology.

[28]  Liwu Li,et al.  Molecular Mechanism Responsible for the Priming of Macrophage Activation* , 2012, The Journal of Biological Chemistry.

[29]  Miao-miao Wei,et al.  Effects of an anthraquinone derivative from Rheum officinale Baill, emodin, on airway responses in a murine model of asthma. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[30]  Alberto Mantovani,et al.  Macrophage plasticity and polarization: in vivo veritas. , 2012, The Journal of clinical investigation.

[31]  G. Natoli,et al.  Transcriptional regulation of macrophage polarization: enabling diversity with identity , 2011, Nature Reviews Immunology.

[32]  R. Barker,et al.  Suppressor of cytokine signaling (SOCS)1 is a key determinant of differential macrophage activation and function , 2011, Journal of leukocyte biology.

[33]  M. Goran,et al.  Subcutaneous Adipose Tissue Macrophage Infiltration Is Associated With Hepatic and Visceral Fat Deposition, Hyperinsulinemia, and Stimulation of NF-κB Stress Pathway , 2011, Diabetes.

[34]  T. Wynn,et al.  Protective and pathogenic functions of macrophage subsets , 2011, Nature Reviews Immunology.

[35]  M. Ko,et al.  Steady-state pharmacokinetics and tissue distribution of anthraquinones of Rhei Rhizoma in rats. , 2011, Journal of ethnopharmacology.

[36]  A. Tefferi,et al.  A CK2-dependent mechanism for activation of the JAK-STAT signaling pathway. , 2011, Blood.

[37]  P. Nagarkatti,et al.  Characterization of Sparstolonin B, a Chinese Herb-derived Compound, as a Selective Toll-like Receptor Antagonist with Potent Anti-inflammatory Properties* , 2011, The Journal of Biological Chemistry.

[38]  M. Netea,et al.  Trained immunity: a memory for innate host defense. , 2011, Cell host & microbe.

[39]  Jai-Sing Yang,et al.  Emodin Induces Apoptotic Death in Murine Myelomonocytic Leukemia WEHI-3 Cells In Vitro and Enhances Phagocytosis in Leukemia Mice In Vivo , 2011, Evidence-based complementary and alternative medicine : eCAM.

[40]  M. Karsdal,et al.  Biochemical markers of ongoing joint damage in rheumatoid arthritis - current and future applications, limitations and opportunities , 2011, Arthritis research & therapy.

[41]  Quanxing Wang,et al.  Immunosuppressive and anti-inflammatory activities of sinomenine. , 2011, International immunopharmacology.

[42]  Kang-jie Chen,et al.  Emodin Prolongs Recipient Survival Time After Orthotopic Liver Transplantation in Rats by Polarizing the Th1/Th2 Paradigm to Th2 , 2011, Anatomical record.

[43]  K. Nakai,et al.  The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection , 2010, Nature Immunology.

[44]  L. Schwarzfischer,et al.  Interleukin-4 induced interferon regulatory factor (Irf) 4 participates in the regulation of alternative macrophage priming. , 2010, Immunobiology.

[45]  Hong Li,et al.  Emodin attenuates acute rejection of liver allografts by inhibiting hepatocellular apoptosis and modulating the Th1/Th2 balance in rats , 2010, Clinical and experimental pharmacology & physiology.

[46]  S. Gordon,et al.  Alternative activation of macrophages: mechanism and functions. , 2010, Immunity.

[47]  A. Chawla.  Control of macrophage activation and function by PPARs. , 2010, Circulation research.

[48]  Y. Dou,et al.  Epigenetic regulation of the alternatively activated macrophage phenotype. , 2009, Blood.

[49]  J. Pollard.  Trophic macrophages in development and disease , 2009, Nature Reviews Immunology.

[50]  O. Issinger,et al.  Resorufin: a lead for a new protein kinase CK2 inhibitor , 2009, Anti-cancer drugs.

[51]  A. Celada,et al.  p21waf1/CIP1, a CDK inhibitor and a negative feedback system that controls macrophage activation , 2009, European journal of immunology.

[52]  J. Edwards,et al.  Exploring the full spectrum of macrophage activation , 2008, Nature Reviews Immunology.

[53]  J. K. Kundu,et al.  Inflammation: gearing the journey to cancer. , 2008, Mutation research.

[54]  G. Srinivas,et al.  Molecular mechanism of emodin action: Transition from laxative ingredient to an antitumor agent , 2007, Medicinal research reviews.

[55]  M. Kizaki,et al.  Emodin has a cytotoxic activity against human multiple myeloma as a Janus-activated kinase 2 inhibitor , 2007, Molecular Cancer Therapeutics.

[56]  K. Honda,et al.  Negative regulation of Toll-like-receptor signaling by IRF-4. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[57]  Wei Zhang,et al.  In vitro effects of emodin on peritoneal macrophage intercellular adhesion molecule-3 in a rat model of severe acute pancreatitis/systemic inflammatory response syndrome. , 2014, Biomedical reports.

[58]  D. Shang,et al.  In vitro effects of emodin on peritoneal macrophages that express membrane-bound CD14 protein in a rat model of severe acute pancreatitis/systemic inflammatory response syndrome. , 2014, Molecular medicine reports.

[59]  A. Shehzad,et al.  Curcumin in inflammatory diseases , 2013, BioFactors.

[60]  M. Bissell.  Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene ExpressionMartinez FO, Gordon S, Locati M, et al (Univ of Milan, Italy; Univ of Oxford, England) J Immunol 177:7303–7311, 2006§ , 2008 .

[61]  J. Xaus,et al.  Interferon gamma induces the expression of p21waf-1 and arrests macrophage cell cycle, preventing induction of apoptosis. , 1999, Immunity.